Back to Journals » Drug Design, Development and Therapy » Volume 14

Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age

Total article views   HTML views PDF downloads Totals
10,399 Dovepress* 8,674+ 1,278 9,952
PubMed Central* 1,725 731 2,456
Totals 10,399 2,009 12,408
*Since 3 June 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar